chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: administered with the vaccine which has been stored in the refrigerator for more than 30 days; administered with the vaccine which has been stored in the refrigerator for more than 30 days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (administered with the vaccine which has been stored in the refrigerator for more than 30 days) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (administered with the vaccine which has been stored in the refrigerator for more than 30 days). On 19-Jul-2021, EXPIRED PRODUCT ADMINISTERED (administered with the vaccine which has been stored in the refrigerator for more than 30 days) had resolved. At the time of the report, PRODUCT STORAGE ERROR (administered with the vaccine which has been stored in the refrigerator for more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   HCP reported that they administered 2 lot numbers of the Moderna COVID-19 vaccine which has been stored in the refrigerator for more than 30 days to 18 patients. The said 2 lots were 039B21A, expiration date 02 Oct 2021 and 048B21A, expiration date 09 Oct 2021, were placed in the refrigerator on 18 Jun 2021. HCP claimed that the vaccines did not experience temperature excursion while in the refrigerator.  This case is for the 16th patient.   This case was linked to MOD-2021-265734 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Confusional state, Feeling abnormal, Palpitations, Thinking abnormal
Clinical narrative: heart feels like it's flipping; I cant gather my thoughts; feeling confused a lot; feeling like the walls was closing in on me; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart feels like it's flipping), THINKING ABNORMAL (I cant gather my thoughts), CONFUSIONAL STATE (feeling confused a lot) and FEELING ABNORMAL (feeling like the walls was closing in on me) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart feels like it's flipping), THINKING ABNORMAL (I cant gather my thoughts), CONFUSIONAL STATE (feeling confused a lot) and FEELING ABNORMAL (feeling like the walls was closing in on me). At the time of the report, PALPITATIONS (heart feels like it's flipping), THINKING ABNORMAL (I cant gather my thoughts), CONFUSIONAL STATE (feeling confused a lot) and FEELING ABNORMAL (feeling like the walls was closing in on me) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.    Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dizziness, Erythema, Feeling abnormal, Insomnia
Clinical narrative: arm was real red; Arm was swollen and huge; Condition aggravated; she was dizzy; it was terrible; doesn't sleep; Arm was painful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy) and FEELING ABNORMAL (it was terrible) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy), FEELING ABNORMAL (it was terrible), INSOMNIA (doesn't sleep) and VACCINATION SITE PAIN (Arm was painful). At the time of the report, ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy), FEELING ABNORMAL (it was terrible), INSOMNIA (doesn't sleep) and VACCINATION SITE PAIN (Arm was painful) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: arm was real red; Arm was swollen and huge; Condition aggravated; she was dizzy; it was terrible; doesn't sleep; Arm was painful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy) and FEELING ABNORMAL (it was terrible) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy), FEELING ABNORMAL (it was terrible), INSOMNIA (doesn't sleep) and VACCINATION SITE PAIN (Arm was painful). At the time of the report, ERYTHEMA (arm was real red), PERIPHERAL SWELLING (Arm was swollen and huge), CONDITION AGGRAVATED (Condition aggravated), DIZZINESS (she was dizzy), FEELING ABNORMAL (it was terrible), INSOMNIA (doesn't sleep) and VACCINATION SITE PAIN (Arm was painful) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain). At the time of the report, CHEST PAIN (Chest pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Bruising; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruising) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thrombocytopenia. Concomitant products included MELATONIN for Insomnia, BIOTIN and MULTIVITAMIN & MINERAL for an unknown indication.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced CONTUSION (Bruising). On 31-Mar-2021, CONTUSION (Bruising) had resolved.            No treatment medications were given. Patient experienced autoimmune issue tested for negative included Von Willebrand disease which was negative.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Administered with the vaccine which has been stored in the refrigerator for more than 30 days; Administered with the vaccine which has been stored in the refrigerator for more than 30 days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days). On 21-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment information was provided.   This case was linked to MOD-2021-265450 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: coughing after vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jul-2021 and was forwarded to Moderna on 23-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing after vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (coughing after vaccine). At the time of the report, COUGH (coughing after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatments were provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Hypersensitivity, Rash
Clinical narrative: developed a reaction to spandex; it burns like fire or like somebody taking knife a knife and sticking into his skin; spandex rash around his pelvic area; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (developed a reaction to spandex), BURNING SENSATION (it burns like fire or like somebody taking knife a knife and sticking into his skin) and RASH (spandex rash around his pelvic area) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (developed a reaction to spandex), BURNING SENSATION (it burns like fire or like somebody taking knife a knife and sticking into his skin) and RASH (spandex rash around his pelvic area). At the time of the report, HYPERSENSITIVITY (developed a reaction to spandex), BURNING SENSATION (it burns like fire or like somebody taking knife a knife and sticking into his skin) and RASH (spandex rash around his pelvic area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Reporter's information, patient information, vaccine information, and events were added.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itchy skin all over body; Welts; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy skin all over body) and URTICARIA (Welts) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR), METFORMIN, POTASSIUM, DILTIAZEM, ACETYLSALICYLIC ACID (ASPRIN) and ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy skin all over body) and URTICARIA (Welts). The patient was treated with PREDNISONE at a dose of 4 doses. At the time of the report, PRURITUS (itchy skin all over body) and URTICARIA (Welts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Rhinorrhoea
Clinical narrative: Feel like I have a cold; Slight runny nose; More fatigue than anything else; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jul-2021 and was forwarded to Moderna on 24-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else). At the time of the report, NASOPHARYNGITIS (Feel like I have a cold), RHINORRHOEA (Slight runny nose) and FATIGUE (More fatigue than anything else) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medicines was not reported by reporter   Treatment information was not provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Lymphadenopathy, Malaise, Myalgia
Clinical narrative: She feels sick; Swollen lymph's; Headache; Sore arm; Sore eyes; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (She feels sick), LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jul-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes). On an unknown date, the patient experienced MALAISE (She feels sick). At the time of the report, MALAISE (She feels sick), LYMPHADENOPATHY (Swollen lymph's), HEADACHE (Headache), MYALGIA (Sore arm) and EYE PAIN (Sore eyes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  No treatment details were provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Headache, Nausea, Pyrexia
Clinical narrative: Back pain; Headache; Some nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 08-May-2021.    On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever). At the time of the report, BACK PAIN (Back pain), HEADACHE (Headache), NAUSEA (Some nausea) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jul-2021, Body temperature: 102 degrees High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was received by the patient No Treatment was received by the patient.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Skin discolouration
Clinical narrative: Pain at fingertips (left hand); Numbness at fingertips (left hand); Fingertips turned blue (left hand); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain at fingertips (left hand)), HYPOAESTHESIA (Numbness at fingertips (left hand)) and SKIN DISCOLOURATION (Fingertips turned blue (left hand)) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jul-2021, the patient experienced PAIN IN EXTREMITY (Pain at fingertips (left hand)), HYPOAESTHESIA (Numbness at fingertips (left hand)) and SKIN DISCOLOURATION (Fingertips turned blue (left hand)). At the time of the report, PAIN IN EXTREMITY (Pain at fingertips (left hand)), HYPOAESTHESIA (Numbness at fingertips (left hand)) and SKIN DISCOLOURATION (Fingertips turned blue (left hand)) outcome was unknown.            Patient went to emergency room and had some tests but didn't figure out what happened exactly. No concomitant medications was reported. No treatment drug details was reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine was administered for the second dose of the patient today 24July2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered for the second dose of the patient today 24July2021) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered for the second dose of the patient today 24July2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine was administered for the second dose of the patient today 24July2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: It's been more than 36 days since caller got the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It's been more than 36 days since caller got the first dose) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (It's been more than 36 days since caller got the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It's been more than 36 days since caller got the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Not feeling very well; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jul-2021 and was forwarded to Moderna on 23-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Not feeling very well) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Not feeling very well). At the time of the report, VACCINATION COMPLICATION (Not feeling very well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medication was reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: dose given to 17 year old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (dose given to 17 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Throw up within hours; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Throw up within hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Throw up within hours). At the time of the report, VOMITING (Throw up within hours) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant drug details were reported. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Weight increased
Clinical narrative: Gain weight after getting Moderna Vaccine; This case was received via an unknown source (no reference has been entered  on 25-Jul-2021 and was forwarded to Moderna on 25-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT INCREASED (Gain weight after getting Moderna Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WEIGHT INCREASED (Gain weight after getting Moderna Vaccine). At the time of the report, WEIGHT INCREASED (Gain weight after getting Moderna Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick... very sick; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Sick... very sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick... very sick). At the time of the report, ILLNESS (Sick.. very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Pruritus, Urticaria
Clinical narrative: Hives (allergic reaction) only one left; Very itchy skin; Headache / Pain in temples / Head hurts so bad; Fatigue / feeling very tired; Felt that something internally move in her chest that woke her up from her sleep; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt that something internally move in her chest that woke her up from her sleep), URTICARIA (Hives (allergic reaction) only one left), PRURITUS (Very itchy skin), HEADACHE (Headache / Pain in temples / Head hurts so bad) and FATIGUE (Fatigue / feeling very tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011D21A and 026D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 22-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 23-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (Felt that something internally move in her chest that woke her up from her sleep). On an unknown date, the patient experienced URTICARIA (Hives (allergic reaction) only one left), PRURITUS (Very itchy skin), HEADACHE (Headache / Pain in temples / Head hurts so bad) and FATIGUE (Fatigue / feeling very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (Felt that something internally move in her chest that woke her up from her sleep) outcome was unknown and URTICARIA (Hives (allergic reaction) only one left), PRURITUS (Very itchy skin), HEADACHE (Headache / Pain in temples / Head hurts so bad) and FATIGUE (Fatigue / feeling very tired) had not resolved.            Patient stated that she otherwise does not take medications, does not smoke and drink alcohol, or take drugs.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Liver function test, Muscular weakness, Product dose omission issue
Clinical narrative: 8 weeks since she received her first dose; Muscle weakness; Dizziness; Burning in throat; Fatigue; Pain on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy and Mononucleosis (diagnosed with mono). Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (8 weeks since she received her first dose). On 13-Jun-2021, MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (8 weeks since she received her first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jul-2021, Liver function test: increased (High) increased. On 08-Jul-2021, White blood cell count: increased (High) increased.         The treatment information was not provided. Patient was not sure about  Autoimmune disease as the patient never diagnosed. She also reported that In London they recommend and administer the second Moderna COVID-19 vaccine beyond 42 days, they believe the body produces more antibody this way.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received on 23-july-21 with second  dose information On 04-Aug-2021: Date of birth, concomitant medication and additional event were added.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Vaccination site pain, White blood cell count
Clinical narrative: 8 weeks since she received her first dose; Muscle weakness; Dizziness; Burning in throat; Fatigue; Pain on the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy and Mononucleosis (diagnosed with mono). Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (8 weeks since she received her first dose). On 13-Jun-2021, MUSCULAR WEAKNESS (Muscle weakness), DIZZINESS (Dizziness), THROAT IRRITATION (Burning in throat), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain on the Injection Site) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (8 weeks since she received her first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jul-2021, Liver function test: increased (High) increased. On 08-Jul-2021, White blood cell count: increased (High) increased.         The treatment information was not provided. Patient was not sure about  Autoimmune disease as the patient never diagnosed. She also reported that In London they recommend and administer the second Moderna COVID-19 vaccine beyond 42 days, they believe the body produces more antibody this way.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Follow-up received on 23-july-21 with second  dose information On 04-Aug-2021: Date of birth, concomitant medication and additional event were added.
Sex: U
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: got their first dose of the Moderna vaccine on 23Feb2021 has not gotten their second dose yet; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (got their first dose of the Moderna vaccine on 23Feb2021 has not gotten their second dose yet) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (got their first dose of the Moderna vaccine on 23Feb2021 has not gotten their second dose yet). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (got their first dose of the Moderna vaccine on 23Feb2021 has not gotten their second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.   Reporter did not allow further contact
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Slight Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight Fever) and HEADACHE (Headache) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included RITUXIMAB (RITUXAN) for Rheumatoid arthritis.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Slight Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Patient had received first dose of Moderna COVID-19 vaccine on 03-JAN-2021 or 04JAN-2021 . Patient had received Rituxan infusion 6 or 7 weeks before vaccination.   This case was linked to MOD-2021-265569 (Patient Link).
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Discomfort, Vaccination complication
Clinical narrative: Blistering breakout in her groin area; Extreme discomfort; Reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blistering breakout in her groin area), DISCOMFORT (Extreme discomfort) and VACCINATION COMPLICATION (Reaction to the vaccine) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included RITUXIMAB (RITUXAN) for Rheumatoid arthritis.   On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blistering breakout in her groin area), DISCOMFORT (Extreme discomfort) and VACCINATION COMPLICATION (Reaction to the vaccine). At the time of the report, BLISTER (Blistering breakout in her groin area), DISCOMFORT (Extreme discomfort) and VACCINATION COMPLICATION (Reaction to the vaccine) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-265564 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Weight increased
Clinical narrative: fever for 24 hours; chills for 24 hours; experiencing weight gain about 5 Lbs. a month and has gained 30Lbs. in total.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for 24 hours), CHILLS (chills for 24 hours) and WEIGHT INCREASED (experiencing weight gain about 5 Lbs. a month and has gained 30Lbs. in total.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024A20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever for 24 hours), CHILLS (chills for 24 hours) and WEIGHT INCREASED (experiencing weight gain about 5 Lbs. a month and has gained 30Lbs. in total.). At the time of the report, PYREXIA (fever for 24 hours), CHILLS (chills for 24 hours) and WEIGHT INCREASED (experiencing weight gain about 5 Lbs. a month and has gained 30Lbs. in total.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant drug details were reported. No treatment details were reported.   Reporter did not allow further contact
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Sharp pains in left shoulder/ sharp pain in his left arm.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sharp pains in left shoulder/ sharp pain in his left arm.) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 011A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), BUMETANIDE (BUMEX), DILTIAZEM HYDROCHLORIDE (CARDIZEM [DILTIAZEM HYDROCHLORIDE]), EZETIMIBE (ZETIA), FAMOTIDINE (PEPCID AC), FLUVASTATIN SODIUM (LESCOL FORTE), METOPROLOL SUCCINATE (METOPROLOL ACTAVIS [METOPROLOL SUCCINATE]), SOLIFENACIN SUCCINATE (VESICARE), TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF) and WARFARIN SODIUM (COUMADIN) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Sharp pains in left shoulder/ sharp pain in his left arm.). At the time of the report, ARTHRALGIA (Sharp pains in left shoulder/ sharp pain in his left arm.) outcome was unknown. Not provided.          Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow-up received on 23-Jul-2021 contains patient demographics and concomitant medication information
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Hypopnoea
Clinical narrative: Shallowbreathing; Has to force  to breath in trough  his upper chest, have to breath deeply, breath hard / anything I do physically I have to sit-down for 10 minutes; Getting tired to go to the bathroom; This spontaneous case was reported by a consumer and describes the occurrence of HYPOPNOEA (Shallowbreathing), DYSPNOEA (Has to force  to breath in trough  his upper chest, have to breath deeply, breath hard / anything I do physically I have to sit-down for 10 minutes) and FATIGUE (Getting tired to go to the bathroom) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 040B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included TRAZODONE, BUPROPION and PAROXETINE for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOPNOEA (Shallowbreathing), DYSPNOEA (Has to force  to breath in trough  his upper chest, have to breath deeply, breath hard / anything I do physically I have to sit-down for 10 minutes) and FATIGUE (Getting tired to go to the bathroom). At the time of the report, HYPOPNOEA (Shallowbreathing), DYSPNOEA (Has to force  to breath in trough  his upper chest, have to breath deeply, breath hard / anything I do physically I have to sit-down for 10 minutes) and FATIGUE (Getting tired to go to the bathroom) had not resolved.            Patient reported that symptoms started 1 week after the second dose and still ongoing after 2 months.  No information regarding treatment was reported by the patient.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain in extremity
Clinical narrative: Leg pain (both legs); Knee pain; Muscle pain (both legs); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Leg pain (both legs)), ARTHRALGIA (Knee pain) and MYALGIA (Muscle pain (both legs)) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011DZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced PAIN IN EXTREMITY (Leg pain (both legs)), ARTHRALGIA (Knee pain) and MYALGIA (Muscle pain (both legs)). At the time of the report, PAIN IN EXTREMITY (Leg pain (both legs)), ARTHRALGIA (Knee pain) and MYALGIA (Muscle pain (both legs)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure measurement, Disturbance in attention, Dysstasia, Heart rate, Hypotension
Clinical narrative: Low blood pressure; Nausea; I have not taken the second dose; Vertigo/ Extreme vertigo; Had a reaction to the first shot; Could not stand without assistance; Could not focus; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo/ Extreme vertigo), HYPOTENSION (Low blood pressure), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance) and DISTURBANCE IN ATTENTION (Could not focus) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VERTIGO (Vertigo/ Extreme vertigo), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance) and DISTURBANCE IN ATTENTION (Could not focus). On an unknown date, the patient experienced HYPOTENSION (Low blood pressure), NAUSEA (Nausea) and PRODUCT DOSE OMISSION ISSUE (I have not taken the second dose). At the time of the report, VERTIGO (Vertigo/ Extreme vertigo), HYPOTENSION (Low blood pressure), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance), DISTURBANCE IN ATTENTION (Could not focus), NAUSEA (Nausea) and PRODUCT DOSE OMISSION ISSUE (I have not taken the second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Low blood pressure. On an unknown date, Heart rate: increased (High) Heartbeats increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given. Event  reported as The first day was severe on JAN-2021   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Event added could not stand without assistance, could not focus, The first day was severe.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Product dose omission issue, Vaccination complication, Vertigo
Clinical narrative: Low blood pressure; Nausea; I have not taken the second dose; Vertigo/ Extreme vertigo; Had a reaction to the first shot; Could not stand without assistance; Could not focus; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo/ Extreme vertigo), HYPOTENSION (Low blood pressure), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance) and DISTURBANCE IN ATTENTION (Could not focus) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VERTIGO (Vertigo/ Extreme vertigo), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance) and DISTURBANCE IN ATTENTION (Could not focus). On an unknown date, the patient experienced HYPOTENSION (Low blood pressure), NAUSEA (Nausea) and PRODUCT DOSE OMISSION ISSUE (I have not taken the second dose). At the time of the report, VERTIGO (Vertigo/ Extreme vertigo), HYPOTENSION (Low blood pressure), VACCINATION COMPLICATION (Had a reaction to the first shot), DYSSTASIA (Could not stand without assistance), DISTURBANCE IN ATTENTION (Could not focus), NAUSEA (Nausea) and PRODUCT DOSE OMISSION ISSUE (I have not taken the second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Low blood pressure. On an unknown date, Heart rate: increased (High) Heartbeats increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given. Event  reported as The first day was severe on JAN-2021   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Event added could not stand without assistance, could not focus, The first day was severe.